Global Heparin Market is poised to witness a CAGR of 5% by 2026 – Increasing Usage of Heparin in Orthopedic and Heart Surgeries

Heparin?is an injectable anticoagulant prescription medicine which is used to treat and prevent the symptoms of?blood clots?caused by medical conditions or medical procedures. It is also used to create an anti-clotting surface inside multiple medical devices such as renal dialysis machines and test tubes.

Increasing Usage of Heparin in Various Applications is Driving the Heparin Market?Growth

Anticoagulants work by decreasing the clotting ability of the blood. It helps to prevent the formation of clots as well as stop the further expansion of any existing clots. Therefore, it can be used in various applications such as as follows:

• Prevent or treat certain blood vessel, heart, and lung conditions.
• Prevent blood clotting during open-heart surgery, bypass surgery, kidney dialysis, and blood transfusions.
• Prevention of?deep vein thrombosis.
• Prevention of a blood clot following percutaneous coronary intervention.

Adoption of Low Molecular Weight Unfractionated Heparin to Prevent Deep Vein Thrombosis or Pulmonary Embolism Fuels its Market Demand

Low-molecular-weight heparins have many benefits over UFH that have led to their growing use for several thromboembolic indications such as deep vein thrombosis (DVT) and pulmonary embolism (PE) as well as atrial fibrillation (AF). LMWH provides better bioavailability and longer half-life, simplified dosing, predictable anticoagulant response, lower risk of heparin-induced thrombocytopenia (HIT), and lower risk of osteoporosis over heparin.

Potential Role of Heparin in Covid-19 Patients Boosts the Global Heparin Market

Many patients with COVID-19 virus develop a clinically significant coagulopathy. COVID-19 infections can lead to an increased risk of blood clots. These blood clots can lead to individuals being admitted to hospital, or, their death. Also, patients with COVID-19 are at high risk for developing clinically significant large-vessel thrombosis.?Therefore, early use of anticoagulation may reduce the risk of coagulopathy, microthrombus formation, and organ damage.

Key Market Challenges: Global Heparin Market

The ill effects associated with the consumption of heparin drugs and the presence of another anticoagulant in the market are the key factors restraining the growth of the heparin market.

North America Holds the Largest Share in Heparin Market but Asia-Pacific is Set to Witness a Healthy Growth

North America holds the largest market share of the heparin market followed by Europe and the Asia Pacific. This can be mainly attributed to the growing burden of chronic diseases, the presence of advanced and robust healthcare infrastructure, an increasing demand for heparin in various surgeries, and growing incidences of cardiovascular disorders in the region.

However, Asia-Pacific is expected to grow significantly during the forecast period as it is the largest supplier base of crude heparin, the rising incidence of venous thromboembolism and cardiovascular diseases, an increasing number of surgical procedures, and a rapid growth in the geriatric population in this region.

Competitive Landscape Analysis: Heparin Market

The global heparin market is marked by the presence of leading market players such as Baxter International Inc. , B. Braun China , Dr. Reddy's Laboratories and Fresenius SE & Co KGaA among others.

Companies are Adopting both Organic & Inorganic Growth Strategies to Increase their Market Share in the Heparin Market

All major players operating in the global heparin market are adopting organic and inorganic growth strategies such as collaborations, acquisitions, and expansions to garner a higher market share. For instance,

• In February 2022, Techdow USA Inc. announced the launch of its Heparin Sodium Injection, USP in the United States market.

Get Detailed Insights on Heparin Market with a Sample Report PDF @ https://meditechinsights.com/global-heparin-market/

#heparin #orthopedics #heartsurgery #chronicdiseases #venousthromboembolism #pulmonaryembolism #cardiovasculardisorders #cardiovasculardiseases #renaldiseases #anticoagulants #surgeries #cancer #coagulation #inflammatorydisease #medicine #bloodclots #medicaldevices #dialysis #dialysismachine #testtube #bloodvessel #hearthealth #lunghealth #bypasssurgery #kidneydialysis #bloodtransfusion #bloodpressure #pharmaceutical #healthcare #medicalcare #marketresearch #researchreport #marketresearchreport